JACK:NASDAQJack In The Box Inc. Analysis
Data as of 2026-04-11 - not real-time
$11.45
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading below its 50‑day and 200‑day moving averages while staying just above the 20‑day average, signaling a bearish medium‑term bias. RSI sits in the low‑mid range, indicating no immediate overbought condition, and the MACD histogram is positive despite both lines being in negative territory, hinting at a tentative bullish crossover. Volume is on the rise, but the 30‑day volatility exceeds 60% and beta is above 1.2, underscoring a highly volatile, market‑sensitive profile. Support sits near the low‑52‑week trough and resistance is just above the recent high, framing a narrow trading range.
Fundamental outlook: Revenue has slipped modestly year‑over‑year and the company posted a negative profit margin, yet operating margin remains positive and EBITDA is solid, suggesting core operations retain profitability. The balance sheet is strained with debt far outweighing cash and a negative book value per share, making the current dividend yield of over 15% appear unsustainable. Forward earnings estimates turn positive and analyst price targets imply nearly 100% upside, but the high debt load, negative equity, and recent earnings miss temper optimism. Overall, the stock presents a deep discount to future expectations but carries significant financial and execution risks.
Fundamental outlook: Revenue has slipped modestly year‑over‑year and the company posted a negative profit margin, yet operating margin remains positive and EBITDA is solid, suggesting core operations retain profitability. The balance sheet is strained with debt far outweighing cash and a negative book value per share, making the current dividend yield of over 15% appear unsustainable. Forward earnings estimates turn positive and analyst price targets imply nearly 100% upside, but the high debt load, negative equity, and recent earnings miss temper optimism. Overall, the stock presents a deep discount to future expectations but carries significant financial and execution risks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below 50‑day and 200‑day SMAs
- High short‑term volatility and beta
- Increasing volume but bearish trend direction
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward EPS turning positive
- Analyst price targets suggest ~100% upside
- Undervaluation indicated by low forward P/E
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Heavy debt burden and negative equity
- Dividend yield likely unsustainable
- Consumer‑cyclical exposure to discretionary spending
Key Metrics & Analysis
Financial Health
Revenue Growth-5.80%
Profit Margin-8.09%
P/E Ratio3.0
ROA4.58%
P/B Ratio-0.2
Op. Cash Flow$75.3M
Free Cash Flow$-25618750
Technical Analysis
TrendBearish
RSI42.9
Support$8.92
Resistance$13.17
MA 20$11.01
MA 50$15.36
MA 200$18.26
MACDBullish
VolumeIncreasing
Fear & Greed Index87.09
Valuation
Target Price$22.88
Upside/Downside99.85%
GradeUndervalued
TypeBlend
Dividend Yield15.71%
Risk Assessment
Beta1.29
Volatility61.50%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.